Company research / VCNX
Vaccinex, Inc. (VCNX)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
For the year ended 2024-12-31, Vaccinex, Inc. reported revenue of $601.0K. Revenue grew 5.4% from the prior annual period.
Key ratios (year ended 2024-12-31)
n/m
Operating margin
n/m
Net margin
5.4%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.